720 people (46 1% males) older than 65 years (mean age: 72 5 +/-

720 people (46.1% males) older than 65 years (mean age: 72.5 +/- A 5.7 years) living in four villages in rural Greece were ACY-738 screened with an electrocardiogram (response rate: 90.5%) for the presence of permanent AF. They underwent a physical examination, including blood pressure (BP) measurement, and body mass index (BMI) calculation, in addition to an interview about their medical history, physical activity, smoking habits, alcohol consumption and medication use. Subjects with AF for whom anticoagulants were contraindicated were identified and stroke risk stratification was performed using the CHADS2 algorithm. The prevalence of permanent AF was 5% (6.6% among men and 3.6% among women) and it increased

with age. In the entire population, ECG evidence of myocardial ischaemia and ventricular premature beats were independently associated with the presence of permanent AF (OR 5.266; 95% CI 2.22-12.49, P = 0.0001 and OR 2.61; 95% CI 1.059-6.432, P = 0.037, respectively), while female sex was independently associated with the absence of the AF (OR 0.327; CI 0.147-0.729, P = 0.006). From those patients who were eligible for anticoagulation, 40.6% were treated with anticoagulants, 34.3% were given antiplatelets therapy and the rest received no antithrombotic treatment. This is the first prospective study demonstrating the prevalence, clinical correlates and treatment status of permanent AF in Greece. These results

confirm the high prevalence of permanent

AF among the elderly and underscore the issue regarding anticoagulants underutilization.”
“The high consumption of blood lipid regulators is leading to frequent reports find more of the occurrence of fibrates in natural streams and wastewater effluents. This paper describes a study undertaken to evaluate the acute toxicity of bezafibrate, clofibric acid, gemfibrozil, and fenofibric acid, a metabolite of fenofibrate whose ecotoxicity has not been previously reported.\n\nThe bioassays used were based on Vibrio fischeri, Daphnia magna, and Anabaena CPB4337 tests. Anabaena CPB4337 is a novel bioassay based on Anabaena sp. PCC 7120 strain CPB4337 bearing in the chromosome a Tn5 derivative with luxCDABE from the luminescent terrestrial bacterium Photorhabdus luminescens.\n\nThe higher toxicity corresponded to fenofibric acid, Ulixertinib order with EC(50) as low as 1.72 mg/l for V. fischeri. Gemfibrozil was also toxic for Anabaena sp. with EC(50) of 4.42 mg/l. The study reports the results from toxicity tests using fortified real wastewater samples taken from the effluent of a wastewater treatment plant. The wastewater itself was found to be very toxic to Anabaena CPB4337 (84% of bioluminescence inhibition) whereas it did not have any negative effect on D. magna or V. fischeri. On the contrary, V. fischeri luminescence exhibited a stimulatory effect in wastewater.\n\nExcept for fenofibric acid, the Anabaena bioassay was more sensitive than the D. magna and V.

Comments are closed.